10/21/2022 Edition 74
----- Division of Research -----
|
|
National Science Foundation |
|
The ACED Fab supports innovative design and fabrication projects of semiconductor chips utilizing advanced technologies of Taiwan’s semiconductor foundries. Proposals are encouraged to target emerging applications (but not limited to): High-performance, low-power circuits and systems; Edge-AI sensing, computing, and communication; Quantum computing and communication chips; and Emerging semiconductor heterogeneous integration.
An ACED Fab proposal must be an integrated collaborative effort between the U.S. and Taiwan researchers. The research project must aim to bring a specific innovation to integrated circuit prototypes that demonstrate advanced functionality and utilize advanced fabrication technology as differentiators. The scope of an ACED Fab proposal must include at least one semiconductor chip design for tape-out utilizing fabrication process technologies of Taiwan’s semiconductor foundries via multi-project wafer runs within the duration of the project.
|
|
Request for Proposals RFP - Real World Evidence for CDK 4/6 inhibitors in Shared Clinical Decision Making - Applications due November 2, 2022 - Specific Area of Interest: The intent of this RFP is to support education and tools to enable clinicians to better analyze, evaluate the quality of, and interpret relevant findings from real world studies of CDK 4/6is in terms of the validity, design, and source, so that they can incorporate this knowledge into their daily practice and shared clinical decision-making discussions with their patients.
|
|
- Increasing the understanding of the mechanism of action, biological and clinical rationale for PARP-inhibitor combinations as potential treatments for prostate cancer. Projects focusing on PARP-inhibitor combinations with androgen receptor targeted therapies are of high interest.
- The evolving paradigm of the potential treatment of mCRPC with future PARP inhibitor combinations.
Pfizer is particularly interested in programs held in conjunction with conferences such as the ASCO GU, AACR and AUA Annual Meetings.
|
|
Request for Proposals RFP - 2022/2023 Global COVID-19 ASPIRE - Letter of Intent (LOI) due November 17, 2022 - Specific Area of Interest: The following areas of research will be considered in-scope:
- Societal impact of COVID-19
- Key populations at high-risk of severe COVID-19 outcomes
- Long term outcomes of COVID-19
- Treatment of mild-to-moderate COVID-19 in vaccinated and or seropositive patients with nirmatrelvir/ritonavir
- Impact of treatment for mild-to-moderate COVID-19 with nirmatrelvir/ritonavir on viral load, infectivity and/or transmission and/or viral rebound and/or symptom resolution
- Regarding use of nirmatrelvir/ritonavir and showing outcomes: prescription behaviors (reason for non-prescription), patient refusal reasons, access and adherence to treatment
|
|
Request for Proposals RFP - Engaging the Patient Community in Research and Publications - Application due December 8, 2022 - Specific Area of Interest: Through this RFP, we intend to provide grants to strengthen the capabilities of the patient community by providing mentorship and training on how to conduct patient-partnered research with the goal to facilitate increased opportunities for collaboration between patients and academic-research communities.
|
|
The Office of Sponsored Programs will be the submitting authorized official for these announcements. We strongly encourage Principal Investigators to utilize the UNLV Corporate & Foundation Relations assistance with the preparation of any narrative portions of the proposal(s).
|
|
Templeton, Sloan, Moore, and Simons Foundations invite LOIs for small scale experiments that advance Fundamental Physics - Up to $1 million per year up to 5 years to support high-risk and potentially high-return small-scale experimental projects aimed at new ambitious discoveries. Letters of Intent due Oct. 31, 2022
|
|
Parkinson’s Foundation invites applications for Impact Awards - Up to $150,000 over 12-18 months to support “outside the box” projects to bring new light to the biology of Parkinson’s, a new approach to Parkinson’s research, or testing a truly novel therapeutic idea. Letters of Intent due Nov. 4, 2022
|
|
Up to $50,000 per year over 2 years to provide seed funding for new projects that have the potential to lead to larger investigations. Priority areas include Diversity, Evaluation of Technological Tools for Suicide Prevention, and Survivors of Suicide Loss.
Distinguished Investigator Innovation Grants - Up to $150,000 over 2 years to support investigators at the level of associate or full professor with an established record of research and publication in the area of suicide.
|
|
Doris Duke Charitable Foundation invites proposals for 2023 Clinical Scientist Development Award - Up to $495,000 over 3 years to early-career physician-scientists (MD, MD/PhD, DO, or foreign equivalent degree) in support of clinical research that will enable them to transition to independent research funding. Pre-proposals due Nov. 17, 2022
|
|
Althea Sheets, Research, Scholarly, and Creative Activities Development Manager, Office of Sponsored Programs, [email protected], 702-895-1880
|
|
|
|
|
|
|
|
